|
|
 Disorder Information - November 21, 2008
| The U.S. Food and Drug Administration on Friday said a drug from Johnson & Johnson appears effective at treating a severe skin disease, but warned that its extended use may raise the risk of cancer. Long-term use of ustekinumab may lead to increased risk of tumor development in psoriasis patients, the federal agency said on its website. The agency added that it still needs more long-term safety data to decide whether the drug increases the risk of cancer | | People with obstructive sleep apnea suffer tissue loss in brain regions that can seriously affect memory, a team of researchers from the University of California Los Angeles have found. After doing MRI scans for tissues on the underside of the brain called mammillary bodies, the team discovered 43 disease sufferers had 20 percent smaller mammillary bodies than 66 participants without the disease | | Two Spanish children have been sent to a mental health institution by their parents to get treatment for addiction to their mobile phones. The children had allegedly ceased to undertake normal activities without first having their phones. The children, aged 12 and 13, were admitted to Child and Youth Mental Health Centre in Lleida, in northeastern Spain near Barcelona, three months ago. Their concerned parents brought them in after they spend an average of six hours a day on their phones, talking, texting or playing games | | A form of the contraceptive coil used by millions of women could help protect women at high risk of womb cancer, British researchers say. The coil releases a hormone which reduces the thickness of the womb wall, potentially halting the growth of abnormal cells. Researchers in Yorkhill Hospital and Glasgow Royal Infirmary are investigating whether a form of the contraceptive coil can stop women from developing womb cancer. If the trial is successful, researchers hope more women will prevent the development of the cancer and so avoid hysterectomies | | The Food and Drug Administration is very close to finalizing new suicide warnings for 11 anti-seizure medications after research showed they increased patients' risk of suicidal thoughts and behavior. In addition to treating epilepsy, the anti-seizure medications are also used for a variety of other illnesses, including migraines, certain nerve-pain disorders, and psychiatric diseases such as bipolar disorder that themselves carry a risk of suicide | |
|
|